a) Mol. weight determination by mass spectra. b) All compounds gave satisfactory elemental analysis.
Quinazolines and condensed quinazolines exhibit diversed pharmacological activities. Of the various quinazolines reported, the C-2 and N-3 disubstituted quinazolines exhibit interesting pharmacological activities like analgesic, 1) antiinflammatory, 2) antibacterial 3) and anticonvulsant 4) activities. Schiff bases possess potent analgesic and anti-inflammatory activities. 5) In the view of these facts and to develop our earlier reporting 6) 2-phenyl-3-substituted quinazoline series that has shown good analgesic and anti-inflammatory activities, in the present study we aimed to synthesize some 2-benzylamino-3-substituted quinazolines, for their analgesic and anti-inflammatory activities. The title compounds 2-benzylamino-3-substituted quinazolin-4(3H)-ones were prepared by reacting 3 amino of 3-amino-2-benzylamino quinazolin-4(3H)-one with various aldehydes and ketones. The starting material 3-amino-2-benzylamino quinazolin-4(3H)-one was synthesized by reacting benzylamine with 3-amino-2-methylthio quinazolin-4(3H)-one, which in turn was prepared from methylanthranilate (Chart 1). The chemical structures of the synthesized compounds were confirmed on the basis of their spectral data (IR, NMR and mass spectra) and the purity was ascertained by microanalysis ( Table 1 ). The synthesized compounds were tested for their analgesic and antiinflammatory activities.
CHEMISTRY
Melting points were determined in open capillary tubes on a Thomas Hoover apparatus and are uncorrected. IR spectra were recorded in KBr on a Perkin Elmer-841 grating Spectrophotometer (cm Ϫ1 ), mass spectra on a Varian Atlas CH-7 mass spectrometer at 70 eV. Elemental analysis was performed on Carlo erba 1108.
Synthesis of 3-Amino-2-mercapto Quinazolin-4(3H)-one To a vigorously stirred solution of methylanthranilate 3.02 g (0.02 mol) in dimethylsulfoxide (10 ml) at room temperature, carbondisulphide (1.6 ml, 0.026 mol) and aqueous sodium hydroxide 1.2 ml (20 mol solution) was added drop- Similarly the compounds II-IV were prepared.
PHARMACOLOGY
The synthesized compounds were evaluated for analgesic and anti-inflammatory activities. Student-t-test was performed for all the activities to ascertain the significance of the exhibited activities. The test compounds and the standard drugs were administered in the form of a suspension (1% carboxyl methyl cellulose as vehicle) in the same route of administration. Each group consisted of six animals.
Animals The animals were procured from "National Biological Center", Madurai, India, and were maintained in colony cages at 25Ϯ2°C, relative humidity of 45-55%, maintained under 12 h light and dark cycle and were fed with standard animal feed. All the animals were acclimatized for a week before use.
Analgesic Activity 7, 8) Test for analgesic activity was performed by "tail-flick technique" using Wistar albino mice (25-35 g) of either sex selected by random sampling technique "Diclofenac sodium" at a dose level of 10 mg/kg, and was administered as standard drug for comparison. The test compounds at a dose level of 10 mg/kg were administered orally. The reaction time was recorded at 30 min, 1, 2 and 3 h after the treatment. The cut off time was 10 s. The percent analgesic activity (PAA) was calculated by the following formula, PAAϭ(T 2 /T 1 )ϫ100
Where T 1 is the reaction time(s) before treatment, T 2 is the reaction time(s) after treatment.
Anti-inflammatory Activity Anti-inflammatory activity was performed by carrageenan-induced paw oedema test in rats.
9) Diclofenac sodium 10 mg/kg was administered as standard drug for comparison. The test compounds were administered at a dose level of 10 mg/kg. The paw volumes were measured using the mercury displacement technique with the help of a plethysmograph immediately before and 30 min, 1, 2 and 3 h after carrageenan injection. The percent inhibition of paw oedema was calculated by using the following formula,
Where x is mean paw volume of rats before the administration of carrageenan and test compounds or standard compound (test group), a stands for the mean paw volume of rats after the administration of carrageenan in the test group (drug treated), b is the mean paw volume of rats after the administration of carrageenan in the control group, y is the mean paw volume of rats before the administration of carrageenan in the control group.
RESULTS AND DISCUSSION
The screening results revealed that all the test compounds (I-IV) showed more potent analgesic activity (Table 2) than our earlier reported 2-phenyl-3-substituted quinazolines. The compound I with N 3 -aliphatic substituent showed good activity, when it was replaced by aryl group leads to increase in activity (compounds II, III), placement of heteroaryl group at N 3 results in retaining activity. The compound III is the most active analgesic agent, it is equipotent with standard diclofenac sodium and more than the earlier reported 2-phenyl-3-substituted quinazolines.
The results of anti-inflammatory activity revealed that all the test compounds protected rats from carrageenan induced inflammation and are more potent (Table 3 ) than our earlier reporting 2-phenyl-3-substituted quinazolines. The compounds I, II and III showed more activity than the standard diclofenac sodium, whereas the compound IV is comparably active with diclofenac sodium. 
